VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $199,796,000 | -55.3% | 12,550 | +185.6% | 0.00% | -71.4% |
| Q4 2015 | $446,752,000 | -98.5% | 4,395 | -97.3% | 0.01% | -98.6% |
| Q3 2015 | $29,365,807,000 | -19.8% | 164,625 | -0.1% | 0.49% | -13.2% |
| Q2 2015 | $36,617,873,000 | +11.8% | 164,834 | -0.0% | 0.57% | +12.9% |
| Q1 2015 | $32,753,232,000 | -10.0% | 164,904 | -35.1% | 0.50% | -14.3% |
| Q4 2014 | $36,381,138,000 | +6.9% | 254,218 | -2.0% | 0.59% | -1.2% |
| Q3 2014 | $34,030,131,000 | +3.5% | 259,376 | -0.5% | 0.59% | +6.3% |
| Q2 2014 | $32,876,457,000 | -3.2% | 260,676 | +1.2% | 0.56% | -9.3% |
| Q1 2014 | $33,966,527,000 | +12.9% | 257,654 | +0.6% | 0.62% | +9.6% |
| Q4 2013 | $30,078,115,000 | – | 256,202 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |